Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vomiting × Esomeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 7 Gastritis 5 Peptic Ulcer 3 Gastroesophageal Reflux 3 Dyspepsia 3 Breast Neoplasms 3 Barrett Esophagus 3 Stomach Ulcer 2 Colorectal Neoplasms 2 Vomiting 1 Radiation Esophagitis 1 Precancerous Conditions 1 Peptic Ulcer Hemorrhage 1 Neoplasm Metastasis 1 Nausea 1 Lymphoma, B-Cell, Marginal Zone 1 Hemorrhage 1 Head and Neck Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1 Esophagitis 1 Esophageal Neoplasms 1 Dysbiosis 1 Colonic Neoplasms 1

Interventions

Dexamethasone 35 Aprepitant 30 Palonosetron 24 Ondansetron 21 Granisetron 14 fosaprepitant 13 Calcium Dobesilate 12 Olanzapine 11 Therapeutics 7 ramosetron 6 dexamethasone acetate 5 Tropisetron 5 Doxorubicin 5 Cyclophosphamide 5 Metoclopramide 4 netupitant, palosentron drug combination 3 netupitant 3 dolasetron 3 dexamethasone 21-phosphate 3 Vincristine 3 Surveys and Questionnaires 3 Prochlorperazine 3 Lorazepam 3 Dronabinol 3 Diphenhydramine 3 Acupressure 3 ginger extract 2 Thalidomide 2 Sugars 2 Radiotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00206440 2018-12-06

NEXIUM

Baylor Breast Care Center

Phase 3 Terminated

43 enrolled 5 charts

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡